These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 31536784)
1. The use of hydrophobic amino acids in protecting spray dried trehalose formulations against moisture-induced changes. Mah PT; O'Connell P; Focaroli S; Lundy R; O'Mahony TF; Hastedt JE; Gitlin I; Oscarson S; Fahy JV; Healy AM Eur J Pharm Biopharm; 2019 Nov; 144():139-153. PubMed ID: 31536784 [TBL] [Abstract][Full Text] [Related]
2. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders. Yu J; Chan HK; Gengenbach T; Denman JA Eur J Pharm Biopharm; 2017 Oct; 119():224-234. PubMed ID: 28655664 [TBL] [Abstract][Full Text] [Related]
3. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders. Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252 [TBL] [Abstract][Full Text] [Related]
4. Investigation of L-leucine in reducing the moisture-induced deterioration of spray-dried salbutamol sulfate power for inhalation. Li L; Leung SSY; Gengenbach T; Yu J; Gao GF; Tang P; Zhou QT; Chan HK Int J Pharm; 2017 Sep; 530(1-2):30-39. PubMed ID: 28709940 [TBL] [Abstract][Full Text] [Related]
5. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation. Shetty N; Park H; Zemlyanov D; Mangal S; Bhujbal S; Zhou QT Int J Pharm; 2018 Jun; 544(1):222-234. PubMed ID: 29678544 [TBL] [Abstract][Full Text] [Related]
6. Leucine as a Moisture-Protective Excipient in Spray-Dried Protein/Trehalose Formulation. Zhang C; van de Weert M; Bjerregaard S; Rantanen J; Yang M J Pharm Sci; 2024 Sep; 113(9):2764-2774. PubMed ID: 38944343 [TBL] [Abstract][Full Text] [Related]
7. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin. Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947 [TBL] [Abstract][Full Text] [Related]
8. The influence of storage relative humidity on aerosolization of co-spray dried powders of hygroscopic kanamycin with the hydrophobic drug rifampicin. Momin MAM; Tucker IG; Das SC Drug Dev Ind Pharm; 2019 Jul; 45(7):1205-1213. PubMed ID: 30990097 [TBL] [Abstract][Full Text] [Related]
9. Leucine enhances the dispersibility of trehalose-containing spray-dried powders on exposure to a high-humidity environment. Wang Z; Wang H; Vehring R Int J Pharm; 2021 May; 601():120561. PubMed ID: 33811968 [TBL] [Abstract][Full Text] [Related]
10. Protective effect of sodium stearate on the moisture-induced deterioration of hygroscopic spray-dried powders. Yu J; Romeo MC; Cavallaro AA; Chan HK Int J Pharm; 2018 Apr; 541(1-2):11-18. PubMed ID: 29454904 [TBL] [Abstract][Full Text] [Related]
11. Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization. Jong T; Li J; Morton DA; Zhou QT; Larson I J Pharm Sci; 2016 Mar; 105(3):1156-63. PubMed ID: 26886330 [TBL] [Abstract][Full Text] [Related]
12. A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery. Focaroli S; Mah PT; Hastedt JE; Gitlin I; Oscarson S; Fahy JV; Healy AM Int J Pharm; 2019 May; 562():228-240. PubMed ID: 30849470 [TBL] [Abstract][Full Text] [Related]
13. Impact of Solid-State Properties on the Aerosolization Performance of Spray-Dried Curcumin Powders. Zhang Q; Li Y; Li L; Cheng Y; Yu F; Li R; Hou S AAPS PharmSciTech; 2023 Mar; 24(3):78. PubMed ID: 36918500 [TBL] [Abstract][Full Text] [Related]
14. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients. Minne A; Boireau H; Horta MJ; Vanbever R Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052 [TBL] [Abstract][Full Text] [Related]
15. Physico-Chemical Properties, Aerosolization and Dissolution of Co-Spray Dried Azithromycin Particles with L-Leucine for Inhalation. Mangal S; Nie H; Xu R; Guo R; Cavallaro A; Zemlyanov D; Zhou QT Pharm Res; 2018 Jan; 35(2):28. PubMed ID: 29374368 [TBL] [Abstract][Full Text] [Related]
16. Characterization of excipient enhanced growth (EEG) tobramycin dry powder aerosol formulations. Hassan A; Farkas D; Longest W; Hindle M Int J Pharm; 2020 Dec; 591():120027. PubMed ID: 33130220 [TBL] [Abstract][Full Text] [Related]
17. Effects of the antibiotic component on in-vitro bacterial killing, physico-chemical properties, aerosolization and dissolution of a ternary-combinational inhalation powder formulation of antibiotics for pan-drug resistant Gram-negative lung infections. Mangal S; Huang J; Shetty N; Park H; Lin YW; Yu HH; Zemlyanov D; Velkov T; Li J; Zhou QT Int J Pharm; 2019 Apr; 561():102-113. PubMed ID: 30797863 [TBL] [Abstract][Full Text] [Related]
18. Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis. Momin MAM; Sinha S; Tucker IG; Doyle C; Das SC Int J Pharm; 2017 Aug; 528(1-2):107-117. PubMed ID: 28583333 [TBL] [Abstract][Full Text] [Related]
19. Nano spray-dried pyrazinamide-L-leucine dry powders, physical properties and feasibility used as dry powder aerosols. Kaewjan K; Srichana T Pharm Dev Technol; 2016; 21(1):68-75. PubMed ID: 25331092 [TBL] [Abstract][Full Text] [Related]
20. Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections. Momin MAM; Tucker IG; Doyle CS; Denman JA; Sinha S; Das SC Int J Pharm; 2018 Apr; 541(1-2):26-36. PubMed ID: 29458207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]